Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Overstock.com, Inc. | OVER | May 31, 2024 | 13.71 | -2.90 |
OVH Groupe | 7U7 | May 31, 2024 | 4.67 | -19.83 |
OVH GROUPE UNSP.ADR/1/2 | 7U70 | May 31, 2024 | 1.93 | -13.84 |
Ovid Therapeutics Inc. | 1OT | May 31, 2024 | 2.78 | +2.21 |
Ovintiv Inc. (DE) | 47Q | May 31, 2024 | 46.12 | +2.22 |
Ovs SPA | 0OV1 | May 31, 2024 | 2.67 | -1.18 |
Ovzon | OVZ | May 31, 2024 | 1.70 | -2.30 |
Owens & Minor, Inc. | 6OM | May 31, 2024 | 15.90 | 0.00 |
Owens Corning Inc | O5Q | May 31, 2024 | 163.15 | +1.18 |
Owl Rock Capital Corporation | 1D6 | May 31, 2024 | 15.36 | +1.03 |
OX2 AB | 4DA | May 31, 2024 | 5.32 | +4.21 |
OXE Marine | 5LK | May 31, 2024 | 0.03 | +10.71 |
Oxford BioDynamics plc | LMQ | May 31, 2024 | 0.05 | +2.04 |
Oxford Biomedica | OXOA | May 31, 2024 | 3.72 | +2.76 |
Oxford Industries, Inc. | OXD | May 31, 2024 | 98.50 | +2.07 |
Oxford Instruments PLC | OX3 | May 31, 2024 | 28.60 | +2.88 |
Oxford Lane Capital Corp. | 4RQ | May 31, 2024 | 4.98 | +0.79 |
Oxford Lane Capital Corp. - 6.25% Series 2027 Term Preferred | 4RQ0 | May 31, 2024 | 21.40 | 0.00 |
Oxford Metrics plc | RNI | May 31, 2024 | 1.26 | +1.61 |
Oxford Square Capital Corp. - Closed End Fund | 22T | May 31, 2024 | 2.81 | -3.11 |
Oxley Holdings Limited | 8OX1 | May 31, 2024 | 0.05 | -8.26 |
Oxurion NV | TG4 | May 31, 2024 | 0.00 | 0.00 |
P10 Inc | AC3 | May 31, 2024 | 7.25 | 0.00 |
P2 Gold Inc Common Shares | 4Z9 | May 31, 2024 | 0.07 | -7.98 |
Pabrik Kertas Tjiwi | OB9 | May 31, 2024 | 0.48 | -1.24 |
PACCAR Inc. | PAE | May 31, 2024 | 96.35 | -0.77 |
PACIFIC BASIN | OYD | May 31, 2024 | 0.31 | -1.64 |
Pacific Biosciences of California, Inc. | P09 | May 31, 2024 | 1.70 | +3.29 |
Pacific Century Regional Developments Limited | PFQ | May 31, 2024 | 0.18 | +0.56 |
Pacific Empire Minerals Corporation Common Shares (Canada) | 1YK | May 31, 2024 | 0.02 | -15.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.